SAVAS PETER G 4
4 · ALSERES PHARMACEUTICALS INC /DE · Filed Jan 16, 2009
Insider Transaction Report
Form 4
SAVAS PETER G
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2009-01-14+950,000→ 950,000 totalExercise: $1.15Exp: 2014-01-31→ Common Stock (950,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2009-01-14−400,000→ 400,000 totalExercise: $3.75From: 2004-09-13Exp: 2014-09-12→ Common Stock (400,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2009-01-14−350,000→ 350,000 totalExercise: $2.50From: 2006-02-06Exp: 2016-01-05→ Common Stock (350,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2009-01-14−200,000→ 200,000 totalExercise: $2.87From: 2007-07-07Exp: 2017-06-06→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]The reporting person agreed to a cancellation of the option granted to him.
- [F2]The reporting person agreed to a cancellation of the option granted to him under the Company's Amended and Restated 2005 Stock Incentive Plan, as amended.
- [F3]Options to purchase 950,000 shares of common stock were granted under the Company's Amended and Restated 2005 Stock Incentive Plan, as amended. The option vests as to 50% of the shares immediately, 25% of the shares on February 28, 2009 and 25% of the shares on March 31, 2009.